Victor Raymond Sawicki Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Ardsley Ave, Northford, CT 06472 Phone: 203-484-9485 Fax: 203-484-7928 |
News Archive
Amira Pharmaceuticals, Inc. announced today that it has successfully identified a novel pre-clinical candidate for its newest lysophosphatidic acid (LPA)-related program, autotaxin. Autotaxin is an enzyme upstream from LPA receptors and has been implicated in a number of diseases including rheumatoid arthritis, glioblastoma, lung, breast, ovarian and thyroid cancers.
Atrium Medical Corporation today announced the publication of the COBEST Trial by the Journal of Vascular Surgery. COBEST (Covered Versus Balloon Expandable Stent Trial) was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that has demonstrated that Atrium's proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease.
Under heavy pressure from government regulators and insurance companies, more and more physicians across the country are learning to think like entrepreneurs. As recently as the late 1990s, there were only five or six joint M.D./M.B.A degree programs at the nation's universities, said Dr. Maria Y. Chandler, a pediatrician with an M.B.A. who is an associate clinical professor in the medical and business schools at the University of California, Irvine. "Now there are 65," she said.
Texas Christian University and the University of North Texas Health Science Center have entered into a memorandum of understanding to create a new MD school in Fort Worth. The school, planning to accept its first class in 2018, will be among the leading institutions in the nation in providing a team-oriented educational approach that benefits patients and shapes the future practice and business of medicine.
Pay-for-performance reimbursement of surgeons, intended to reward doctors and hospitals for good patient outcomes, may instead be creating financial incentives for discriminating against obese patients, who are much more likely to suffer expensive complications after even the most routine surgeries, according to new Johns Hopkins research.
› Verified 4 days ago